Cargando…
Intra- and interspecies gene expression models for predicting drug response in canine osteosarcoma
BACKGROUND: Genomics-based predictors of drug response have the potential to improve outcomes associated with cancer therapy. Osteosarcoma (OS), the most common primary bone cancer in dogs, is commonly treated with adjuvant doxorubicin or carboplatin following amputation of the affected limb. We eva...
Autores principales: | Fowles, Jared S., Brown, Kristen C., Hess, Ann M., Duval, Dawn L., Gustafson, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759767/ https://www.ncbi.nlm.nih.gov/pubmed/26892349 http://dx.doi.org/10.1186/s12859-016-0942-8 |
Ejemplares similares
-
Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma
por: Das, Sunetra, et al.
Publicado: (2021) -
MicroRNA Expression Changes and Integrated Pathways Associated With Poor Outcome in Canine Osteosarcoma
por: Dailey, Deanna D., et al.
Publicado: (2021) -
Expression profiling in canine osteosarcoma: identification of biomarkers and pathways associated with outcome
por: O'Donoghue, Liza E, et al.
Publicado: (2010) -
Expression of Bcl-2 in canine osteosarcoma
por: Piro, F., et al.
Publicado: (2015) -
A systematic analysis of genomics-based modeling approaches for prediction of drug response to cytotoxic chemotherapies
por: Mannheimer, Joshua D., et al.
Publicado: (2019)